Emergent Biosolutions Inc

NYSE:EBS   12:47:27 PM EDT
32.47
-1.27 (-3.76%)
Products

Emergent BioSolutions Hid Evidence Of Quality Control Problems From FDA In Feb 2021 - NYT

Published: 05/10/2022 13:36 GMT
Emergent Biosolutions Inc (EBS) - Emergent Hid Evidence of Quality Control Problems From FDA in Feb 2021, Six Weeks Before It Alerted Officials That 15 Million Doses Was Contaminated - Nyt.
Further Company Coverage: Ebsn ((reuters.
Briefs@thomsonreuters.
Com;)).